当前位置: 首页 > 期刊 > 《中国实用医药》 > 2010年第3期
编号:13196489
不同冠心病炎症因子测定及意义(2)
http://www.100md.com 2010年1月25日 孙小军 卢竞前 李 易
第1页

    参见附件。

     参 考 文 献

    [1] Schonbeck U, Libby P. CD40 signaling and plaque instability.Circulation research, 2001,89(12):1092-1103.

    [2] Conti CR. Updated pathophysiologic concepts in unstable coronary artery disease. Am Heart J, 2001,141(2 suppls):S12-S14.

    [3] Davies MJ. The pathophysiology of acute coronary syndromes. Heart,2000, 83(3):361-366.

    [4] Oltrona L, Ardission D, Merlini PA,et al.C-reactive elevation and early outcome in patients with unstable angina pectoris.Am J Cardiol,1997,80(8): 1002-1006.

    [5] Blake GJ,Ridker PM.C-reactive protein and other inflammatory risk markers in acute coronary syndromes.J Am Coil Cardiol,2003 ,41(4SupplS):S37-S47.

    [6] Ridker PM,Bassuk SS,Toth PP.C-reactive protein and risk of cardiovascular disease: Evidence and clinicial application. Curr Atheroscler Rep, 2003, 5(5):341 -349.

    [7] Bruemmer D, Riggers U, Holzmeister J, et al. Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions. Am J Cardiol, 2001,87(1):21-27.

    [8] Francesco C,Claudio F,Giovambattista D. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation,2003, 108(22):2776-2782.

您现在查看是摘要介绍页,详见PDF附件